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1. Introduction
The female pelvis is an anatomic region which is quite complex, because it contains some
organs and systems accomplishing different and independent functions. The uro-genital
system represents the main part of the female pelvis but there are also portions of other or‐
gans and systems such as some important blood vessels, gastrointestinal tracts, lymphatics,
nerves and parts of the musculoskeletal system. All these structures might house or generate
pelvic masses even in para-physiologic conditions, and not necessarily because of current
diseases, or congenital alterations, inflammatory illness and tumours.
In order to  understand the nature of  a  pelvic  and/or abdominal  mass it  is  necessary to
collect as many as possible clinical data. A clinical classification constitutes the first step
for finding out the aetiology.  The age is  indicative for diseases linked to different func‐
tional  periods  of  the  reproductive  system;  clinical  history  must  investigate  upon  possi‐
ble  previous  tumours,  infectious  or  metabolic  diseases  and  surgery.  When  collecting
clinical  history,  pelvic  pain  which  can  be  divided  into  acute,  chronic  and  cyclic,  must
be  directly  addressed;  alterations  of  body temperature,  gastrointestinal  symptoms (nau‐
sea,  vomiting,  diarrhoea,  constipation,  hematemesis,  melena),  urinary  tract  symptoms
(oliguria,  polyuria,  stranguria,  hematuria,  urinary  retention,  incontinence),  taste  disturb‐
ance;  pharmacological  treatment  in  progress  (anticoagulants),  previous  radiotherapy
must be addressed.
The are several gynaecological causes responsible for pelvic tumours. These are reported in
table 1.
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SITE DISEASE
Ovary:
endometriosis
organic and functional cysts
benign and malignant cancers
metastasis
Fallopian tube:
tubo-ovarian abscesses, pelvic inflammatory disease
hydrosalpinx
para-ovarian cysts
ectopic pregnancy
neoplasm
Uterus:
uterus body neoplasm
fibroma
malformations
blood-pyometra
Table 1. Gynaecological abdominal-pelvic masses with malignant clinical features.
It has also to be taken into account the possibility that a non gynaecological lesion could be
responsible for a mass. In table 2 the principal non-gynaecological causes for pelvic and ab‐
dominal swellings are reported.
The role of medical imaging
The best examination in a clinical context is undoubtedly suprapubic and endovaginal ultra‐
sonography. In young patients, especially in those who are in the reproductive age, ultraso‐
nography shows the best accuracy in the differential diagnosis of ovarian and hydrosalpinx
cysts, of the ectopic pregnancy, of uterine fibroids [1].
Ultrasonography permits to distinguish correctly between a benign and a malignant adnexal
mass and, within these groups of diseases, to give an accurate diagnosis in most of the cases.
Nevertheless ultrasonography isn’t free from errors and limitations. Diagnostic errors are
probable in the identification of masses which appear solid at US. In these cases is difficult
to evaluate the uterine or ovarian or the extra-gynaecologic origin of the lesion. These cases
require CT or MRI scan. In particular MRI has proven to be useful in detecting and staging
of gynaecological malignancies and in detecting the origin of extra-gynecological pelvic
masses [2].
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SITE DISEASE
Gastro-intestinal tract
appendicular abscess
neoplasms
diverticulitis, peridiverticular abscess
Crohn’s disease, segmental ileitis
impaction
mesenteric cysts
Urinary tract
pelvic kidney
bladder globe
urachus cyst
bladder tumours
Miscellany
lymphadenopathy
peritoneal carcinomatosis
musculo-skeletal tumours
organ ectopia (migrant spleen)
pelvic vessel aneurysms
foreign bodies
pelvic dysmorphisms
complications of previous surgery
hematomas
musculo-skeletal inflammations
Table 2. Abdominal-pelvic extra gynaecological masses with malignant clinical features
2. Intra peritoneal extra gynaecological masses
2.1. Digestive system
They are intra peritoneal masses which originate from the gastrointestinal system, are local‐
ized in the pelvis and concern essentially tumours and inflammatory diseases. It is to be tak‐
en into account that, especially in adolescents and old patients who have a very long sigma,
the loop can be palpated in the pouch of Douglas simulating, when full of faeces, an ovarian
neoplasm.
In adolescents this condition can be caused by colon-sigma non-ganglionic diseases (mega-
colon), where the altered peristalsis implies an abnormal accumulation of faecal material.
This condition can also imply the invagination of intestinal traits which is not so infrequent
especially in old patients. Among the digestive system diseases, which very frequently can
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simulate a gynaecological neoplasm, we count inflammatory diseases (acute and chronic)
and tumours.
2.2. Inflammatory diseases
An acute, but mainly chronic, inflammation could cause the clinical evidence of an abdomi‐
nal-pelvic mass and the reasons are the following:
• formation of adhesions in intestinal loops, causing wall thickening and rigidity, sub mu‐
cosa and mesentery bleeding and oedema, inflammatory reaction of peritoneum and adja‐
cent omentum.
• bowel perforation and formation of peri-visceral phlegmon; in some cases the wall break‐
ing causes the bleeding of an important vessel and shows the symptoms of haemorrhagic
or peritonitic acute abdomen.
These anatomic-pathological aspects correspond to different CT scan findings, classified by
Hinchey and his team in 4 stages, depending on the inflammation extension [3]:
• Stage 0: inflammatory thickening of the intestinal wall, with oedema of the mucosa, lumi‐
nal-stenosis, the inflammation being still circumscribed within the bowel wall.
• Stage I-II-III: abscesses, unique or multiple, showing sometimes air-fluid level images
connectible to liquid necrosis; generally these abscesses are adherent to the intestinal wall,
or to the peritoneal folds. Such a picture corresponds to the condition of the diffusion of
the inflammation beyond the visceral wall.
• Stage IV involves intestinal perforation and faecal invasion of the peritoneum (Figure 1).
Figure 1. Contrast enhanced CT scan, during a portal phase showing an inflamed sigma, with perforated diverticulum
in the medial side of the sigma.
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The intestinal  inflammation (whether  circumscribed or  widespread)  might  cause fistulas
with adjacent  anatomical  regions  and/or  the  most  declivous portions  of  the  pelvis  such
as the vagina and the rectum. The fistula is often the first symptom of the intestinal wall
inflammation.
Besides, in patients with generalized sepsis, CT scan is useful for correctly positioning of
drainage  pipes  into  the  abscesses  in  order  to  clean  them  up  by  saline  and  antibiotic
washes [4].
2.3. Neoplasms
Sigma-rectum tumours determine swellings of the left adnexal site, but they may also occu‐
py the whole pelvis or the central portion of it. These tumours might appear as solid masses
stenosing the intestinal trait where they originate from, or, rarely, masses with mainly extra
luminal development.
Not infrequently, the tumoural mass associate with an intestinal inflammatory disease.
Nonetheless, the mesenteric vessel congestion and the presence of small perivisceral liquid
collections, appear to be the CT scan signs which are most related to diverticulitis and, to a
lesser degree, tumours.
When the neoplasm does not involve the pelvic organs the CT scan diagnosis is simple and
easy, showing the reproductive system integrity. Thought not infrequently, an intestinal prim‐
itive neoplasm may strictly stick to, and infiltrate the uterus; there might also be observed ad‐
nexal neoplastic masses which are not in direct continuity with original neoplasm (Figure 2).
Figure 2. Preoperative axial contrast enhanced CT scan during late phase showing a mass growing in the left ovary
(white arrow). An adjacent mass is seen in in the sigmoid colon.
In these cases CT scan is unable to discriminate between a primitive ovarian neoplasm with
peritoneal metastasis infiltrating the sigma-rectum, and a primitive intestinal tumour with
adnexal metastasis (Krukenberg disease).
Differential Diagnosis for Female Pelvic Masses
http://dx.doi.org/10.5772/53139
331
2.4. Intra peritoneal foreign bodies
The presence of foreign bodies into the peritoneal cavity represents a not so infrequent find‐
ing; they are a consequence of surgical malpractice and that’s why they’re also known as
“gossypiboma”. A “textiloma” is a complex made of a non- biodegradable foreign body plus
the surrounding reactive tissue [5].
The pelvis can be site of textiloma either because of pelvic or abdominal surgery. In fact the
position of the textiloma is affected by the omentum causing the foreign body phagocytosis
with consequent fibrinoid-granulomatous reaction and strong adhesions. In this case the
textiloma remains into the abdomen. If the surgery implies the removal of the omentum
then the textiloma can move to the pelvis. In the case of pelvic surgery, the gossybipoma
seems to have greater possibilities of changing its original position and moving either to the
pelvic or the abdominal peritoneal cavity.
Recently, in operating rooms, sterile gauze with a radio-opaque marker is being used.
Ultrasonography might be useful in the differential diagnosis of garzomas; they appear as
cystic masses, containing the foreign body in their core, with a rather irregular morphology
and completely reflecting ultrasonic waves.
At CT scan the finding of a solid mass containing helical, or vortex-like opacities, or the
presence of differently dense micro nodules, sometimes calcified, are very suggestive of tex‐
tiloma. The solid part might be expression of the exudative reaction, while the fibrinoid re‐
action has a less specific meaning. After c.m. administration a slight peripheral enhancement
of the pseudo-capsula. In this case the differential diagnosis with abscesses is very difficult.
At MRI they appear as a solid mass hypointense on T1 and hyperintense on T2, with no spe‐
cific morphologic features [6].
2.5. Ascites
Very rarely some intraperitoneal liquid collections might be considered as reproductive-sys‐
tem originating tumours. This may happen under particular conditions: patients who un‐
derwent previous surgery for abdominal masses; in the cases of intraperitoneal treatment
with radioactive drugs where are present so strong adherences causing intraperitoneal fluid
flow alterations. Bags of peritoneal effusion may also appear, and they are correctly identi‐
fied by ultrasonography as liquid masses that can be exchanged as intraperitoneal masses.
CT scan results better in defining the liquid bag topography which has low density values
(0-10 HU), excluding, more safely, the possibility for the mass to be an intraperitoneal cyst.
2.6. Peritoneal pseudomixoma
It is the accumulation of mucinous material into the peritoneal cavity. It is due to peritoneal
metastatic lesions secreting mucin; in most of the cases the principal cause is a mucinous
ovarian neoplasia, but less frequently pseudomixomas can be due to malignant mucocele of
the appendix and tumours of the stomach, of the colon, of the pancreas and of the breast.
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The pseudomixoma typical CT scan appearance is a hypodense, liquid mass localized
among the intestinal loops; sometimes, inside the lesions, can be observed images of septa or
solid buttons. The HU values range between 15 and 30.
2.7. Mesenteric panniculitis
It’s a primitive disease of the mesentery, with intraperitoneal and pelvic metastasis. It is de‐
fined as macrophage inflammatory infiltration of the mesenteric fat associated with scar-fi‐
brous component. When this last element prevails, it is defined as liposclerosis. Panniculitis
might be also consequent to previous abdominal surgery or radiotherapy.
CT scan is decisive for diagnosis: a fatty mass incorporating some mesenteric vessels with‐
out infiltrate them; the mass is homogeneous, circumscribed by a peripheral pseudocapsule
well delimited. MRI fat suppression sequences further discriminates the fat components
from the liquid ones. These aspects can be unique, affecting portions of the abdominal-pel‐
vic peritoneum with multiple foci.
2.8. Intraperitoneal tumours
Tumours of omentum and intraperitoneal spaces originate from the tissues which constitute
these structures: coelomic epithelium, mesothelium, fiber, fat and muscle connective tissue,
lymphatic and blood vessels, nerves, embryonic residues. Usually, lesions in these sites are
due to primitive abdominal tumours, especially intestinal and ovarian. Therefore, given an
intraperitoneal neoplastic mass, it has first to be considered as a metastasis unless a primi‐
tive tumoural lesion is found elsewhere.
Peritoneal tumours can be cystic (dermoids, lymphangiomas, benign and borderline serous,
micropapillary cystadenomas) and solid (serous, micropapillary cystoadenocarcinoma, ma‐
lignant mesothelioma, small round cell desmoplastic tumour, fibroma, desmoids tumour,
and others). Tumours morphology is often non-specific both at US and CT scans; It might
appear either solid or cystic depending on the kind of tissue they are made of. In some
casese they cannot be distinguished from mesenteric cysts. The more are the solid compo‐
nent and the complex aspect, the more must be the suspect of the mass being malignant.
3. Extra/retro peritoneal originating extra gynaecologic masses
3.1. Urinary system
In pre-ultrasound age was the most frequent pelvic mass the pelvic kidney originating from
urinary system, an extremely easy ultrasound diagnosis even in the gynaecologic area. It is
also possible that a pelvic supernumerary kidney leads to the same error.
Occasionally, great kidney-originating masses spreading to the pelvic retro peritoneum can
simulate reproductive-system tumours; the same goes for huge cysts, or gigantic hydro‐
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nephrosis. CT scan and MRI can, instead, easily establish the urinary-system origin of the
retroperitoneal lesions.
Other causes for urinary-system originating extra-gynaecologic masses are malformations
resulting from Müller ducts alterations associated to Wolff ducts malformations. The most
frequent are represented by uterus didelfus with blind hemi-vagina. In the latter the mass is
constituted of blood and mucus blocking the vagina. There might also originate some pock‐
ets of pelvic endometriosis, which are expression of abdominal reflux of vital endometrium.
Finally, even an atresic hemi-horn, with or without communicating endometrium, can be a
pelvic mass.
A bladder globe might resemble a pelvic mass in patients who underwent radical hysterec‐
tomy surgery or radiotherapy which damaged the bladder innervation and caused large
stagnation. The bladder can also be site of extrinsic-diffusion tumours, or huge pseudo-di‐
verticula resembling adnexal masses.
The urachus may be a site of inflammatory processes. Cysts are caused by persistence, of the
intermediate tract of the urachus, after birth which doesn’t communicate with either the
bladder or the navel and therefore may house a very slow-growing liquid collection. It ap‐
pears macroscopically as a spherical, cystic formation with muscular-fibres and urothelium-
constituted walls containing clear, citric liquid and urea. It might be an occasional finding
during an ultrasonography or a CT exam. The middle position, the front site (between the
Linea Alba and the parietal peritoneum) and the round appearance can easily suggest the
origin. These cysts, if inflamed, might be confused with pelvic inflammations.
3.2. Alterations of the sacral canal
By these terms are meant malformations of the sacral canal which is the inferior portion of
the vertebral canal. In the sacral canal are contained the spinal meninges, the final portion of
the cauda equina and the epidural space between the meninges and the bone walls; often
such malformations associate with alterations of kidney, bladder and urinary system-
growth. The malformation that is most simulating an adnexal pelvic mass is the anterior, sa‐
cral meningocele. This is constituted of meningeal herniation through anterior defects of the
sacrum-coccyx. They can be either unique or associated with more complex malformations
of the terminal thread, as in the caudal regression syndrome, in the generalized mesenchy‐
mal dysplasia (neurofibromatosis type 1 or Marfan syndrome).
The mass appears as a simple cyst, homogeneous and anechoic at US.
CT scan, but mainly MRI can precisely detect the origin of the lesion. It is possible to study
the alterations of the sacrum, anterior defects, and the whole morphology of the sacrum-coc‐
cyx using sagittal reconstruction with CT. The mass is like a simple cyst, with no enhance‐
ment and without capsule.
The main signal characteristic is T2 hyperintensity at MRI. Finally, both CT and MRI is able
to perfectly detect the neck of the meningocele (Figure 3).
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Figure 3. MPR sagittal reconstruction of a CT scan showing an anterior sacral meningocele direcly connected to the
medullar canal.
3.3. Pelvic, retroperitoneal tumours
From pelvic retroperitoneum can originate benign or malignant tumours, whose histology
might cover all the tissues normally present in the retroperitoneum; mesenchyme: sarcomas,
leiomyosarcomas, fibrosarcomas; adipose tissue: lipomas, liposarcomas; nervous system: be‐
nign and malignant schwannomas, paragangliomas, neurogenic tumors; hemangiomas: ma‐
ture and immature teratomas.
The evaluation of these masses is difficult by US. The most preferred techniques are still CT
and MRI.
CT imaging appearance is that of a solid mass, only rarely homogeneous in density; it is so
mainly as far as neurologic benign tumours (benign schwannomas) or masses rich in well-
differentiated striated muscle component (neurofibromas) are concerned. Malignant masses
are inhomogeneous, infiltrating the retroperitoneal structures.. Edged and regular contours,
the footprint of the surrounding structures without infiltration suggest the benignity.
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The masses rich in fatty component, given their retroperitoneal origin, are usually histologi‐
cally malignant and aggressive; these masses must be distinguished from all pelvic intraper‐
itoneal lipomas. Factors of malignity are represented by the inhomogeneity, the infiltrative
character of the edges and the presence of a rich, solid tissue component.
Neurofibromas are solid, neurogenic benign tumours which show enhancement in CT. Both
CT and MRI are the first-choice techniques of investigation in the suspect of a pelvic, retro‐
peritoneal mass; this is due to their ability in the topographic localization of the mass and
the good ability in the tissue characterization. Probably MRI reaches higher results in the di‐
agnostic accuracy (easy characterization of lipomas, liposarcomas and mature teratomas). If
a definitive diagnosis can't be reached by CT or MRI, then guided needle biopsy can be use‐
ful. In figure 4 a MRI scan of a schwannoma is presented.
Figure 4. MRI T2-weighted sagittal scan showing a retroperitoneal oval-shaped solid lesion (white arrow) in straight
contact with the anterior part of the sacrum, which turned out to be a schwannoma.
They must be considered, finally, other rare, non-gynecological causes for pelvic masses,
represented by neoplasias originating from different tissues of the pelvis. We can therefore
report some cases of anterior abdominal wall muscles fibromas, pelvic sarcomas, aneurys‐
mal dilatation of the iliac vessels.
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4. Tumoural markers
It has been proved that serum Ca125 are helpful in the diagnostic evaluation of pelvic masses,
particularly in adnexal masses.
An increase (ranging from 80 to 90%) of Ca125  serum levels are associated with ovarian,
epithelial,  malignant,  non-mucinous  tumours.  Besides,  Ca125  is  related  to  the  volume of
the tumour mass.  Ca125  represents the gold standard tumoural  markers for ovarian can‐
cer  in  two  different  clinical  conditions:  as  a  diagnostic  tool  for  evaluating  the  risk  of
malignancy  of  an  adnexal  mass  and as  a  monitoring  tool  in  the  evaluation  of  the  dis‐
ease state, in patients already treated for adnexal cancer [7,8].
Ca125  serum levels  equal  or  below 35  U/ml  are  normal.  Ca125  serum levels  greater  then
50-65 U/ml (in the 80-90% of postmenopausal patients)  is  associated with a malignancy.
Classifying  patients  with  increased  Ca125  and  a  pelvic  mass  by  age,  permits  a  rise  in
positive  predictive  value  of  the  association  of  80%  in  patients  older  then  50  and  only
50% in younger ones.
On the other hand this marker increases (in 60-70% of the cases) also in advanced endome‐
trial adenocarcinoma and/or in recurrence.
Other gynaecological malignant solid tumours can increase Ca125 serum levels (60% in pan‐
creatic cancer, 20-25% in breast, lung and colon tumours). Other non tumoral conditions can
be associated with increased levels of Ca125 such as endometriosis, peritonitis, tubo-ovarian
abscess, diverticulitis, adenomyosis, uterine fibroids, ascites.
Best specificity and sensitivity results have been reached by integrating different diagnostic
techniques like markers and ultrasonography and clinical history to create risk index [9].
5. Gynaecological masses: Assessment of malignity/benignity criteria
based upon morphologic and multiparametric ultrasonography
Female  pelvic  masses  are  mainly  caused  by  gynaecological  diseases.  For  classificatory
purposes it’s important to know whether the disease originates from the uterus or from
the ovaries.  This is often difficult to establish, that’s why we tend to use another classi‐
fication  based  on  malignity/benignity  criteria.  In  this  case,  the  main  goal  of  the  radiol‐
ogist  is  to  characterize  the  mass  from  a  histological  point  of  view,  using  different
imaging techniques.
The imaging main parameters are:
• size and shape;
• vascularisation;
• associated signs.
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As far as size is concerned we can say that the bigger the ovarian mass, the higher is the
probability that that mass is malignant.
As far as shape is concerned it must be considered the presence of septa, solid components
(papillary excrescences) and mass echogenicity.
The presence of septa highly increases the probability of malignity. This finding becomes
more relevant when associated with the thickness of the septa.
The presence of papillary excrescences or solid lesions inside or outside a cystic mass is
highly suggesting of malignity.
Ultrasonography permits distinguishing between cystic or solid masses. A certain mass is
defined as cystic when the content echogenicity is liquid, with back wall shadowing. On the
contrary, a completely solid mass is characterized by more or less homogeneous, multiple
internal echoes, giving it a parenchimal-like appearance. Generally speaking it can be said
that the higher the echogenicity of a mass the higher the risk of malignity.
In table 3 the most important echographic morphological criteria for the definition of malig‐
nancy scores are reported.
Simple ovarian cyst, very likely to be benign:
diameter of less than 5 cm
thin, smooth walls
anechoic content
lack of septa or less than 3, thin septa
no liquid into the Douglas space
no solid intracystic vegetations
Complex ovarian cyst likely to be malignant:
diameter greater than 5 cm
smooth, thick walls
hypoechoic or solid, homogeneous content
more than 3 thin septa
a bit of liquid in the Douglas space
no solid, intracystic vegetations
Malignant ovarian cyst:
diameter greater than 5 cm
thick, irregular, nodular walls
many thick septa
intracystic, solid component
intraperitoneal carcinomatosis
Table 3. Echographic morphological criteria for the definition of malignancy scores.
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Morphological scores for the prediction of malignancy of the masses have been made up by
ultrasonography.
Historically the parameters evaluated were size (currently it is considered an adnexal mass a
lesion with a diameter greater than 4 cm), echogenicity (considering the masses as solid,
simple cystic, complex cystic ), presence and shape of septa (single or multiple, whether or
not associated with vegetating solid components adhering to them), and persistence over
time of the tumour.
Since 1974, Kobayashi reported a 70% diagnostic accuracy of ultrasound in the differentia‐
tion of ovarian cancer from other pelvic tumours. The presence of papillae, nodules and
thickened septa within cysts were elements suggestive of malignant adnexal disease [10]. In
1979 De Land showed how the risk of malignancy increased linearly with the increase of the
solid component within the mass [11]. More recently, Hermann, in 1987, classified the pelvic
masses into three categories in relation to the morphological complexity: simple cystic
forms, complex forms and solid forms [12].
In 1989 Grandberg went another step further, precisely defining others parameters. He de‐
fined: the number of the intracystic papillae, the solid, intracystic component percentage
and the presence of septa, reporting the malignancy risk percentage for each of those pa‐
rameters [13].
In 1990 Jacobs tried to introduce a multifactorial score for the diagnosis of malignancy. He
did it considering: the gynecological examination, the trans-abdominal ultrasound and the
determination of serum Ca125.  It was devised an echographic-morphological score assign‐
ing the value 1 to each parameter: multiloculated cyst, presence of solid spots, evidence of
metastasis, presence of ascites, bilateral adnexal lesions. All these parameters were includ‐
ed in  an analysis  that  showed how statistically  significant  were  the  age,  the  postmeno‐
pausal status, the ultrasound score, the Ca125 value and the clinical impression. This score
has been defined as RMI (risk of malignancy index) [14]. In 1992 Kuriak linked flow met‐
ric data obtained by Colour Doppler to the morphologic score proposing a multiparamet‐
ric score [15].
Recently, in 2011 a new scoring sistem was proposed called Pelvic Masses Score (PMS). It
takes into account the Sassone score, the base 10 logarithm of the Ca125 level, the central/
septal vascular distribution, the menopausal state and the resistance index [15, 16,17].
Currently, morphological scores have been extensively used in clinical practice mainly be‐
cause they allowed a better morphologic characterization of pelvic masses.
The vascularisation of a pelvic mass is the second element for a diagnosis of malignancy.
Once again, ultrasonography represents the first step in the evaluation of this data. The echo
color Doppler examination of a pelvic mass has to be performed when there are masses
which are strongly suspected to be malignant. Clearly benign masses don’t need such ex‐
Differential Diagnosis for Female Pelvic Masses
http://dx.doi.org/10.5772/53139
339
amination. Nevertheless the echo color Doppler examination may be very useful in the in‐
terpretation of a mass which isn’t clearly benign [15].
The pathogenic factor that justifies the use of colour Doppler in the differential diagnosis of
a pelvic mass nature, is represented by the fact that the tumour’s new vessels lack a muscu‐
lar coat, and that causes low resistance to blood flow, generating low Pulsatility Index and
Resistive Index values and absence of diastolic notch.
Besides it has to be considered that the flowmeter samples must be multiples and collected
from different parts of the mass, that is, not only from the periphery but, more importantly,
from the core of the mass. In fact, we believe that many malignant tumours tend to start the
new vessel production from the centre of the mass, while peripheral lesion vessels may re‐
sult from preexisting vessels. A peripheral vascularization of the mass is basically benign,
often deriving from ipsilateral uterine artery. Intralesional vascularisation and the presence
of vessel in the solid component of the mass or in the septa or papillae, are elements that
strongly suggest malignancy. The vascular confluence represents another indication of ma‐
lignancy [18].
6. Ovarian benign and malignant tumours: Anatomical and pathological
classification
Malignant ovarian tumours represent the fifth death cause among US female population;
the sixth neoplasia for frequency, the second, most frequent female tumour after endometri‐
al ones and the first death cause as far as gynaecologic tumours are concerned [19].
This illness is more frequent in peri-or post-menopausal women, but there are characteristic
histological types for each age group. In adolescents and in women who are younger than
20, half of the tumours comes from germ cells; in post menopausal age they have a most fre‐
quent epithelial origin.
The causes for the occurrence of ovarian cancer are not defined; epidemiological studies
show that the most affected people by ovarian cancer are represented by peri or post-meno‐
pausal, middle or upper class, with no children or just one and with problems in getting
pregnant women.
The majority of ovarian tumors begins without well-defined symptoms; as a matter of fact
early stages are mostly incidental findings representing just a 20%. In most of the cases they
are diagnosed when they are at an advanced stage, that is when the cancer has spread out‐
side the pelvis. The most common symptoms are given by the effect on neighbouring or‐
gans: polyuria, dysuria, constipation, sudden increase in abdominal circumference,
amenorrhoea, polymenorrhea.
In table 4 WHO histological classification of the tumours of the ovary is presented.
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TYPES SUBTYPES
Surface epithelial-stromal tumours
Serous tumors
Mucinous tumors
Endometrioid tumors (including variants with squamous differentiation)
Clear cell tumours
Transitional cell tumours
Squamous cell tumours
Mixed epithelial tumours (specify components)
Undifferentiated and unclassified tumours
Sex cord-stromal tumours
Granulosa-stromal cell tumours
Sertoli-stromal cell tumours
Sex cord-stromal tumours of mixed or unclassified cell types
Steroid cell tumours
Germ cell tumours
Primitive germ cell tumours
Biphasic or triphasic teratoma
Monodermal teratoma and somatic-type tumours associated
with dermoid cysts
Germ cell sex cord-stromal tumours
Tumours of the rete ovarii Adenocarcinoma, adenoma, others
Miscellaneous tumours Small cell carcinoma, Hepatoid carcinoma, Wilms tumours, others
Tumour-like conditions Luteoma of pregnancy, Stromal hyperthecosis, Stromal hyperplasia,Fibromatosis, others
Lymphoid and haematopoetic tumours Malignant lymphoma, Leukemia, Plasmacytoma
Secondary tumours Gastro-intestinal tract (stomach, colon, pancreas), Breast, Renal cellcarcinoma, Melanoma, Others
Table 4. WHO histological classification of tumours of the ovary.
7. FIGO staging
Ovarian tumours spread by contiguity, through the intra peritoneal route, by blood and
lymphatic. 9% of cases in advanced stage show intra peritoneal carcinomatosis, and 70% as‐
cites.
In table 5 the ovarian tumour FIGO staging is reported [19].
The adnexal masses invasion by contiguity is the direct infiltration of the adjacent anatomi‐
cal structures. Hence the bladder can be involved through neoplastic deposits in the vesico-
uterine fold. The sigma-rectum can also be involved through the rectovesical pouch. In both
cases the tumour infiltration very rarely reaches the mucosa.
The intraperitoneal tumour spreading follows the physiologic routes. The most affected sites
are: the rectovesical pouch, the para-colic gutters (especially the right one), and the right
sub-diaphragmatic peritoneum.
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The omentum, through its phagocytic function, collects cancer cells and constitutes an ovari‐
an cancer typical site for cell proliferation. Lymphatic drainage of the ovary in the pelvis
and, in the para aortic zone through the infundibulum pelvic ligament, permits the pelvic
and lombo-aortic lymphatic metastatic spreading. Neoplastic emboli, reach the left subclavi‐
an vein through the thoracic duct, penetrate into the bloodstream and stop in the lung. Pul‐
monary involvement happens directly through both ovarian veins and the pelvic venous
plexus. Upper abdominal metastases (most of the cases liver and spleen) seem to be related
to blood-borne neoplastic emboli originating from the sigmoid and superior haemorrhoidal
plexus.
STAGE DESCRIPTION
I Tumour limited to ovaries
IA one ovary affected, no ascites, absence of capsular infiltration, absence of neoplastic proliferations on the
outer surface of the mass;no malignant cells in ascites or peritoneal washings.
IB Tumour limited to both ovaries; capsule intact, no tumour on ovarian surface; no malignant cells in ascites
or peritoneal washings.
IC Tumour limited to one or both ovaries with any of the following: capsule ruptured, tumour on ovarian
surface, malignant cells in ascites or peritoneal washings
II Tumour affecting one or both ovaries with pelvic extension
IA Extension and/or implants on uterus and/or tube|s|;no malignant cells in ascites or peritoneal washings
IB Extension to other pelvic tissues; no malignant cells in ascites or peritoneal washings
IC Pelvic extension (2a or 2b) with malignant cells in ascites or peritoneal washings
III Tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside
the pelvis and/or regional lymph node metastasis
IIIA Microscopic peritoneal metastasis beyond pelvis
IIIB Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension
IIIC Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node*
metastasis
IV Distant metastasis (excludes peritoneal metastasis)
Note: Liver capsule metastasis is T3/stage III, liver parenchymal metastasis M1/stage IV. Pleural effusion
must have positive cytology for M1/stage IV.
NOTES The classification applies to malignant surface epithelial-stromal tumours including those of borderline
malignancy. (Non-epithelial ovarian cancers may also be classified using this scheme).
*. Regional lymph nodes are the hypogastric (obturator), common iliac, external iliac, lateral sacral, para-
aortic, and inguinal nodes.
Table 5. Ovarian tumours FIGO staging
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8. Indications for CT scans and MRI.
The use of CT and of MRI in the preoperative phase of malignant ovarian tumours it’s a
debated argument even today. A correct diagnosis can be done using only ultrasound, as
reported in this chapter. However, it is essential to know the CT and MRI appearance of
these tumours mainly because they are easy to compare in investigations performed for
other purposes.
In literature there are numerous publications which compare ultrasound, CT and MRI for
their ability to distinguish between malignant and benign pelvic masses. The CT reaches a
specificity and sensibility of about 92,8 and 88% respectively based on the morphology of
the lesions and their vascularization after the injection of Contrast Material [20,21].
In our Institution all MDCT studies were performed using a 64-multislices MDCT system
(Somatom Sensation 64, Siemens medical solutions, Forchheim, Germany). MDCT images
were obtained from the abdomen and pelvic, covering the area from the diaphragm to the
symphysis pubis (craniocaudal). The contrast medium (IOVERSOL 350 mg /ml – Optiray,
Covidien Imaging Solutions, Hazelwood, MO) was administered at a dose of 1.5 mL per
kg,  with a  variable  flow rate  of  3-4  mL per  second through the antecubital  vein of  the
right arm.
MRI with paramagnetic contrast Material, on the other hand, not only distinguishes better
gynaecological lesions from non-gynaecological ones, but also allows a better tissue charac‐
terization of the mass. The CT aspect of an ovarian malignant mass is characteristic though,
as ultrasound, it is not able to define the anatomical-pathological variant. The mass can be
localized exclusively in the adnexal site or, if size is conspicuous, involve the entire pelvic
region. Sometimes, when the whole pelvis is filled with the tumour, it is impossible to make
out the adnexal origin. The masses are usually complex with thickened and often nodular
walls. Not infrequently there are numerous intralesional septa delimiting different chambers
which vary in density and are not communicating with each other. Solid components, usual‐
ly growing in the liquid section of the mass, are often present at the confluence of the thick‐
ened septa. An ovarian cancer very rarely infiltrates the retroperitoneal pelvic structures
reaching the bone wall.
Even though it’s large and closely adjacent to bladder and bowel, this cancer very rarely
fully infiltrates these structures’ walls, and if there were infiltrations they’d just involve
some peritoneal folds and the rectovesical pouch. The nodular peritoneal dissemination can
be correctly evaluated by CT scan in the presence of ascites which facilitates the detection of
nodules adhering to the intestinal tract and between the mesenteric sheets. The parenchymal
nodules adhering to hepatic peritoneum, gastro-colic, gastro-duodenal and spleno-gastric
ligament, are more easily distinguishable. An indirect sign of peritoneal microscopic infiltra‐
tion is the rigidity of the peritoneal layers taking a radial, rail and fanned aspect. When the
omentum is highly involved than it’s called “omental cake”finding. The great omentum,
which has the function of filtering the free, peritoneal liquid, becomes the site of neoplastic
solid metastases, sometimes very large, which often join, forming a neoplastic plaster adher‐
ent to the anterior parietal peritoneum [22].
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At MRI, the malignant ovarian cancer appears as a big, heterogeneous solid and cystic mass.
The solid component shows, in T1, low or intermediate signal intensity, while the intensity
is quite high in T2. This aspect, however, can be conditioned by the presence of intra lesional
haemorrhagic foci, or areas of necrosis. Also the cystic component of the complex mass can
have a different signal behaviour. The malignant cystic, ovarian tumours contain abundant
proteinaceous or haemorrhagic material causing a high signal intensity both in T1 and in T2.
After intravenous paramagnetic contrast material injection, some thickening of the capsule
can also be detected, with the presence of septa or intra-cystic vegetations which can be ei‐
ther associated to the mass solid component or not. By gadolinium administration it is ob‐
tained an optimal characterization of the solid components of the complex adnexal mass [23]
Lately, Diffusion weighted Imaging (DWI) as a useful tool to improve the radiological diag‐
nosis of malignant tumors, especially for endometrial and cervical tumours. Concerning
ovarian cancer, while initially promising DWI in cystic ovarian tumors proved to be limited,
particularly for differentiating benign from malignant lesions [24–25]. In a large retrospec‐
tive analysis the majority of malignant ovarian tumors, mature cystic teratomas, and endo‐
metriomas exhibited abnormal signal intensity on DWI, whereas benign lesions did not. A
Few studies addressed the use of DWI for peritoneal dissemination of gynaecological cancer
assessment: a high sensitivity (90%) and specificity (95.5%) in evaluation of peritoneal dis‐
semination was proven. Nevertheless, the study population was small [24,25].
Preoperative evaluation of upper abdominal organs by ultrasonography or CT scan is im‐
portant. At the disease onset, in fact, spleen or liver metastases are frequently found accord‐
ing to the tumour stage [26]. For this reason, staging must always include the study of upper
abdominal organs. The intraperitoneal, often multifocal, spread of the ovarian cancer is very
frequent and well assessable by both CT and MRI (Figure 5).
Figure 5. A Contrast Enhanced CT scan showing typical intraperitoneal calcified implants in a serous papillar ovarian
cancer (III stage FIGO classification).
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The results of preoperative CT and MRI in advanced stages of ovarian cancer can predict the
success of the radical surgery. The residual post-surgery tumor must be absent or of a diam‐
eter less than 2 cm. This is a very important goal: in these conditions the patients respond
better to chemotherapy and have a more favorable prognosis. Through a quantitative score
that examines five common anatomic, frequently affected by the disease sites by CT scan,
one can select the patients who are eligible to the initial radical treatment. The criteria for the
tumor unresectability include the presence of metastases with a diameter greater than 2 cm
localized in the following sites: mesenteric root; gastro-splenic ligament; epiploic pouch;
hepatic hilum; hepatic, intrasegmental peritoneal reflection; diaphragm and liver dome. Be‐
sides other unresectability criteria are: lymphadenopathy greater than 1 cm above the celiac
zone; presence of extraperitoneal, presacral disease [26].
9. Adnexal inflammation, tubo-ovarian abscesses and Pelvic
Inflammatory Disease (PID)
By the term PID it’s meant female genitalia inflammations not only affecting reproductive
organs but also the whole pelvic zone, including the pelvic peritoneum. From a pathogenet‐
ic point of view PID includes primary and secondary forms, representing In the primary
forms, which represent more than 90% of the cases, the inflammation affects initially the
lower genital tract (cervico-vaginal tract), spreading subsequently to the uterus, the adnexal
glands up to the pelvic peritoneum. In the pathogenesis exogenous factors are involved of
such as sexually transmitted germs and instrumental factors; or endogenous factors as in the
case of the pathological transformation of cervico-vaginal saprophyte flora. The secondary
forms,which are quite rare, are determined from the diffusion to the internal genitalia,
through blood, lymphatic or by contiguity, of pathogenic microorganisms from extragenital
outbreaks: pyelitis, cysto-pyelitis, cystitis, colitis but especially appendicitis, peri-appendi‐
ceal abscess, diverticulitis.
For each pathogenic PID form there have been recognized risk factors. In the case of the
primitive exogenous venereal PID they are represented by the young age, frequency and
precocity of sexual relationships, number of partners and sex during the menstrual phase.
In the case of primitives exogenous iatrogenic PIDs the most important risk factors are: the
use of intrauterine devices (IUD), voluntary termination of pregnancy, endometrial biopsies,
hysteroscopy, hysterosalpingography and tubal insufflation. The PID aetiology needs to be
continuously updated. It is currently considered to be poly-microbial. We assisted to a re‐
duction of the pathogenic role of Neisseria gonorreae down to 15-20% compared to associa‐
tion of both aerobic and anaerobic germs: streptococci, staphylococci, E.Coli (10-40%);
Mycoplasma (10-30%), Chlamydia trachomatis (40-60%). PID includes several pelvic diseas‐
es clinically distinguishable into acute and chronic forms. Acute infections are caused by
uterine cervical flora that spreads from the mucosal surface to the uterus and fallopian
tubes, finally affecting the pelvic and/or abdominal peritoneum. The subacute and chronic
form widely varies in extension and severity, including tubal lesions with the formation of
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pelvic liquid collections and connectival reaction widespread, or by formation of extensive
and tenacious adhesions. In order to have an accurate and early PID diagnosis it is essential
to the use of imaging techniques. Laparoscopy is essential not only for recognizing the dis‐
ease but also in order to isolate the pathogenic germs, favouring a targeted therapy.
Based on the laparoscopic findings there are three distinct forms of acute salpingitis, each
with different prognostic significance:
• light form: the tubes are hyperemic, edematous, covered with exudate or by deposits of
fibrin, but are mobile and with patent ostia;
• moderate form: the signs are more evident and there are doubts about the ostia patency;
• serious form: there is pelvic and peritoneal inflamnation with closed ostia and/or abscess
formation.
Ultrasonography was used to confirm the pelvic abscess clinical diagnosis, thanks to its ac‐
curacy, sensitivity and specificity. Compared to laparoscophy, endovaginal ultrasonography
can recognize almost all of the cases of severe tubal damage, but just 65% of slight tubal
damage. Ultrasonography is also very helpful in the follow-up of pelvic inflammation pa‐
tients, for evaluating the effectiveness of therapy.
On the other hand ultrasonography may be negative both in the acute and in chronic salpin‐
gitis. In PID detection of some liquid into the recto-vescical pouch, it may result easy with
US, and it may have a higher diagnostic value whenever the liquid presented diffuse or in‐
homogeneous echogenicity, indicating a blood or purulent collection.
CT scan is not so useful as far as mild and moderate forms are concerned; it’s crucial in the
recognition and evaluation of the chronic PID.
MRI seems to be very useful in the diagnosis of this disease; it is in fact possible to character‐
ize the inflammation activity, better distinguishing the acute state from the subacute and
chronic ones.
The salpingitis initial phase, which is characterized by hyperemia and edema, can be lapa‐
roscopically evaluated but not by ultrasound, CT scan and MRI. However, it is a very short
lasting phase and is rarely demonstrated even by a early laparoscopy. Salpingitis often fol‐
lows and is associated with endometritis which can be sonographically demonstrated: the
uterus is large, with loss of normal endometrial echogenicity and with irregular, undefined
borders; sometimes the cavity may contain hypoechoic material. Even CT scan and MRI
don’t show, at this stage, any ovarian alterations, while in the presence of endometritis non‐
specific uterine abnormalities can be detected: hyper- hypodense endocavitary formations
(due to liquid collections) with no enhancement after CM injection.
In the exudative phase, exudate collects in the tubes, covers the fimbrial peritoneum and can
spill out of the still open tubal ostium, or, when it’s closed, the tubes stretch and become fil‐
led with exudate (laparoscopically moderate or severe PID).
By ultrasound, adnexal region appears magnified, with well-defined contours and with a
cystic appearance; begins to form a multilobed, often multisepted, sausage-like mass. The
Medical Imaging in Clinical Practice346
content can be more or less echogenic depending on the blood or exudative component. In
some cases of this last condition some pseudo-niches determined by thickening of the tubal
mucosa are observable inside the dilated tube.
By CT scan the adnexal region may appear swollen and inhomogeneous; after the CM ad‐
ministration it can be highlighted a marginal rim of intense enhancement delimiting the var‐
ious ectatic portions of the tube. The pious-sactosalpinge has a more or less folded
intestinal-like appearance and by this feature it can be distinguished from other ovarian liq‐
uid formations; the density is varying from serous to corpuscular (Figure 6).
Figure 6. MPR coronal reconstruction of a Contrast Enhanced CT scan during portal phase showing bilateral swelling
of the tubes which have an intestinal like appearance in a sactosalpingitis (white arrows).
If an early therapy it hasn’t been established, the next step of the inflammation involves the
involvement of the ovary. The bag filled with pus extend the the fallopian tubes and ovarian
parenchyma making them lose their cleavage planes, wrapped by tenacious adhesions. The
tubo-ovarian abscess rupture (3.5%) is a surgical emergency. The tubo-ovarian abscess ap‐
pears as an adexal or retro-uterine mass, often with internal baffles and sometimes images
of gaseous levels. During the appropriate antibiotic treatment the mass becomes better de‐
fined and cystic. It can often be found some liquid into the recto-vescical pouch and endo
uterine abnormalities can coexist. The echo color Doppler may be helpful in the mass char‐
acterization. The hyperaemia and angiogenesis caused by acute inflammation result in an
increase of both systolic and diastolic flow velocity, with decreased PI and RI. These altered
flow conditions may be reversible during the gradual disappearing of the inflammation. The
differential diagnosis must consider the acute salpingitis with sactosalpinx, the tubarian pio‐
cele, other conditions of chronic pelvic inflammation without masses.
CT scan, at this stage, detects the adnexal or retro-uterine mass. After CM administration, in
the most acute forms, may be evident an intensely enhanced, marginal rim, which is a typi‐
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cal sign of ongoing inflammation. In the acute and sometimes even in chronicle forms the
central part of the swelling presents various densities but not contrast enhancement; some‐
times there are baffles which delimit internal chambers. In chronic forms the mass may
present irregular contours, inhomogeneous density and contrast enhancement.
In neglected cases and in those which do not respond to treatment, the inflammation ex‐
tends to the entire pelvic peritoneum, the bowel, the contralateral ovary, the bladder and the
ureters. The anatomical-pathological framework includes peritoneal inflamnation, distant
abscesses and, in the chronicle evolution, adhesions between peritoneal organs, inflammato‐
ry infiltration of the peritoneum and retroperitoneal tracts.
By ultrasonography, the pelvis appears very irregular showing ill-defined, irregular con‐
toured masses with both solid and liquid component; under these conditions, the uterus and
the ovaries can be indistinguishable. It can be associated, in this framework, hydrouretero‐
nephrosis.
CT scan easily recognizes the pelvis structural-anatomical upheaval. By CT scan/MRI certain
signs are very obvious which, if present, provide an accurate picture of the disease severity.
These signs are: fascial and peritoneal thickening; peri-rectal, peri-vescical, intestinal, pre-sa‐
cral, pre-vescical and latero-pelvic fat’s increase in density and inhomogeneities; involve‐
ment of extra-genital structures; masses that can be dumped to the uterus, may spread to the
recto-vescical pouch and to the parametrium. The contours are irregular and hazy [27].
MRI seems to play an important role in the diagnosis of pelvic inflammation as can be used
in the initial phase of the disease (the exudative one), or in the tubo-ovarian abscess and pel‐
vic peritonitis. By MRI, the tubo-ovarian abscess appears as a simple or complex cystic mass,
with irregular but neat and well defined walls. The cystic component has signal intensity
similar or modestly higher than fluid one (low T1 signal and high T2 one); only rarely it may
present a high protein content and therefore a blood-like signal (Figure 7).
Figure 7. Axial MR scan of a bilateral acute salpingitis. Huge dilatation and bilateral swelling of the tubes can be seen.
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10. Metastatic tumours
Ovarian metastatic tumours are quite frequent: they are about 5-10% in the US, and 15-18%
in Japan. On Imaging it has to be always considered the possibility of a metastatic tumour
whenever a pelvic mass is found. Nevertheless is has been observed that even using all the
different imaging methods and machines they can’t differentiate with certainty a primary
pelvic mass from a secondary one. Both by ultrasonography and CT scan have been descri‐
bed the Krukenberg tumours whose pattern may greatly vary. The common gastric Kruken‐
berg presents a solid, homogeneous, bilateral mass pattern (Figure 8), while the metastasis
from colon-rectum have a more often cystic, complex, necrotic pattern.
Figure 8. Contrast enhanced CT during portal phase showing two heterogeneously enhanced round masses in a pa‐
tient suffering from gastric cancer. Histology of the resected masses showed signet-ring cells consistent with Kruken‐
berg metastases.
At US gastric Krukenberg tumours can be bilateral, consisting of complex masses with dif‐
ferent percentages of solid and cystic components, frequently associated with ascites. At CT
scan Krukenberg tumours are described as mainly solid, with rich peripheral C. E., with
cystic component in the cortical or intralesional site masses. The cystic components’ walls
present a high C.E.
At MRI It is represented by a solid, T2 hypointense, consisting of dense stromal tissue com‐
ponent. It has been than observed that when an apparentely malignant adnexal mass is bi‐
lateral, shows well defined but irregular contours, is associated with peritoneal
carcinomatosis without ascites, it is 7 times more likely to be a Krunenberg than a primary
ovarian tumor.
11. Cystic ovarian teratomas
Mature cystic ovarian teratomas are benign tumours recognisable, using various imaging
techniques, by certain characteristics. Already from direct examination of the pelvis, it is
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possible to obtain very clear images showing teeth-like characteristics, either singular or
grouped from a common germinal follicle.
The appearance of dermoid cysts at US is highly variable and depends on the homogeneity
and composition of the newly formed tissue. The calcifications inside the mass, character‐
ised by acoustic barriers, are not, however, pathognomonic, as they are also seen in other
benign tumours (Brenner) or in malignant adnexal masses. Similar images can be also fre‐
quently observed in teratomas and it is possible to recognise not only the Rokitansky pro‐
tuberance, but also the presence of skin appendages, locks of hair, sebum and glands. The
fatty component can also present crude images indicating acoustic barriers, located within a
fluid; this is due to varying acoustic impedance of different fat components.
The ultrasound morphology of the mass can be that of a homogenous formation, with ele‐
vated echogenicity and a solid appearance; on the other hand it can appear as a cystic for‐
mation, either simple or complex depending on the acoustic impedance of the intralesional
structures. In some cases, the ultrasound cannot provide a definite diagnosis of teratoma
and in others it cannot exclude malignant characteristics.
In CT scans however, the appearance of dermoid cysts is often pathognomonic. CT is the
ideal method to evaluate tissue fatty components, leading to a correct diagnosis in case of
adnexal fatty mass. Even when other hypodense tissue, like sebum and hair, are present, the
fat is recognisable and the, usually, polymorphic appearance in the ultrasound is defined
more clearly. CT scans can also correctly identify calcification, better define their morpholo‐
gy and therefore reach a diagnosis. In CT scans it is also very easy to identify fat buoyancy,
a pathognomonic sign of dermoid cysts (Figure 9).
Figure 9. A Contrast Enhanced CT scan showing a huge lesion in the left hemipelvis (white arrow). A fluid –fat level
can be seen within the lesion; there is a heterogeneous floating part with soft tissue density. This lesion turned out to
be a dermoid cyst.
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Even in magnetic resonance imaging (MRI) the diagnosis of dermoid cysts is based on the
evidence of fat within the lesion. T1 and T2 weighted images are not enough for this pur‐
pose and so fat suppression techniques need to be implemented (Figure 10).
Figure 10. T2-weighted images non-fat saturated (left picture) with fat saturation (right picture) in a MRI scan of a
patient with a pelvic mass (white arrow), showing a heterogeneous mass in the left ovary in which there is a signal
drop in fat saturated image. The mass proved to be a dermoid cyst.
A differential diagnosis is necessary for endometriotic and mucinous cysts. Diagnostic diffi‐
culties may arise when there is a small fat component, or a high levels of hematic content
that masks the fatty signals. MRI can correctly evaluate fatty levels and fat buoyancy com‐
ponents, like the Rokitansky nodule; these semiological aspects help differentiate diagnosis.
Chemical shift artifacts caused by the presence of fat are also useful in the diagnosis of der‐
moid cysts. Intravenous administration of gadolinium causes contrast enhancement of the
cyst walls and of the Rokitansky nodule [28,29].
Mature teratomas are, in most cases, benign tumours; on occasion, there may be an imma‐
ture component, with malignant characteristics; this occurs in about 1% of all benign terato‐
mas. The tumour most commonly associated with the teratoma is the squamous-cell
carcinoma.
Malignancy signs in a dermoid are indicated by tissue showing clear enhancement. In addi‐
tion, as the malignant component often infiltrates different dermoid tissues, the capsule, or
the extracapsular anatomic structures, it is possible to assess the nature of the cyst by its ag‐
gressive morphological appearance. Complications of cystic dermoids are represented by
ovarian torsion, or by acute rupture of the mass in the peritoneum.
It is also important to remember that a dysontogenetic pelvic mass may not necessarily orig‐
inate from the ovary. Sacrococcygeal teratoma and primary retroperitoneal teratomas are
more frequent. Sacrococcygeal teratomas are most common dysontogenetic masses in in‐
fants; the diagnosis can also be done in uterus, with direct ultrasound visualisation of a pre-
sacral mass often associated with polyhydramnios. In many cases the masses are visible
externally, developing in the subcutaneous tissue of the intergluteal area;
The masses can have macroscopic appearances, ranging from predominantly cystic, to
mixed, to predominantly solid; the last one is most likely to be malignant.
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Imaging plays an important role in the diagnosis of these tumours: firstly, through CT ad
MRI scans it is possible to differentiate between other abnormalities of the terminal filum
such as meningocele and myelomeningocele. It is possible to identify other abnormalities al‐
so associated with teratomas in the sacrococcygeal area. Rarely it’s possible to observe the
growth into the vertebral canal or bone destruction due to teratoma. The association with
anal stenosis, vesicoureteral reflux, presacral abscess and skin changes may be indicative of
Currarino syndrome.
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